2010 annual financial data
Sarepta Therapeutics 2010 Operating margin
Sarepta Therapeutics 2010 operating margin with verified reported values.
Direct answer
Operating margin was -71.16%.
Operating income was -20,934,000 USD and net income was -32,177,000 USD.
Operating cash flow was -15,209,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 29,420,000 USD
- Operating income
- -20,934,000 USD
- Net income
- -32,177,000 USD
- Operating cash flow
- -15,209,000 USD